Literature DB >> 16283050

Estimating the burden of shigellosis in Thailand: 36-month population-based surveillance study.

Pornthip Chompook1, Seksun Samosornsuk, Lorenz von Seidlein, Supot Jitsanguansuk, Nunta Sirima, Sanit Sudjai, Prasitchai Mangjit, Deok Ryun Kim, Jeremy G Wheeler, Jim Todd, Hyejon Lee, Mohammad Ali, John Clemens, Pramuan Tapchaisri, Wanpen Chaicumpa.   

Abstract

OBJECTIVE: To estimate incidence of shigellosis in the Kaengkhoi district, Saraburi Province, Thailand.
METHODS: Population-based surveillance of shigellosis based in treatment centres. The detected rates of treated shigellosis were corrected for the number of cases missed due to the low sensitivity of microbiological culture methods and participants' use of health-care providers not participating in the study.
FINDINGS: The overall uncorrected incidence of shigellosis was 0.6/1000 population per year (95% confidence interval (CI) = 0.5-0.8). The unadjusted incidence of treated shigellosis was highest among children less than 5 years old (4/1000 children per year; 95% CI = 3-6) and significantly lower among people aged > 5 years (0.3/1000 population per year; 95% CI = 0.2-0.5; P < 0.001). Adjusting for cases likely to be missed as a result of culture and surveillance methods increased estimates approximately five times. The majority of Shigella isolates (122/146; 84%) were S. sonnei; the rest were S. flexneri. Of the 22 S. flexneri isolates, the three most frequently encountered serotypes were 2a (36%), 1b (23%) and 3b (28%). A total of 90-95% of S. sonnei and S. flexneri isolates were resistant to tetracycline and co-trimoxazole. In contrast to S. sonnei isolates, more than 90% of the S. flexneri isolates were also resistant to ampicillin and chloramphenicol (P < 0.0001).
CONCLUSION: Estimates of incidence of Shigella infection in the community are 10-fold to 100-fold greater than those found from routine government surveillance. The high prevalence of Shigella strains resistant to multiple antibiotics adds urgency to the development of a vaccine to protect against shigellosis in this region of Thailand.

Entities:  

Mesh:

Year:  2005        PMID: 16283050      PMCID: PMC2626425          DOI: /S0042-96862005001000010

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  32 in total

1.  A novel low-cost approach to estimate the incidence of Japanese encephalitis in the catchment area of three hospitals in Bangladesh.

Authors:  Repon C Paul; Mahmudur Rahman; Emily S Gurley; M Jahangir Hossain; Serguei Diorditsa; Asm Mainul Hasan; Sultana S Banu; Asm Alamgir; Muhammad Aziz Rahman; Hardeep Sandhu; Marc Fischer; Stephen P Luby
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

Review 2.  Shigella flexneri: an emerging pathogen.

Authors:  Iqbal Nisa; Muhammad Qasim; Nusrat Yasin; Rafi Ullah; Anwar Ali
Journal:  Folia Microbiol (Praha)       Date:  2020-02-05       Impact factor: 2.099

3.  Shigella: A Highly Virulent and Elusive Pathogen.

Authors:  Mussaret Bano Zaidi; Teresa Estrada-García
Journal:  Curr Trop Med Rep       Date:  2014-06-01

4.  Shigellosis in Subjects with Traveler's Diarrhea Versus Domestically Acquired Diarrhea: Implications for Antimicrobial Therapy and Human Immunodeficiency Virus Surveillance.

Authors:  Carlos Toro; Ana Arroyo; Ana Sarria; Nuria Iglesias; Ana Enríquez; Margarita Baquero; Concepción Ladrón de Guevara
Journal:  Am J Trop Med Hyg       Date:  2015-07-20       Impact factor: 2.345

5.  A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation.

Authors:  Ha Vinh; Nguyen Thi Khanh Nhu; Tran Vu Thieu Nga; Pham Thanh Duy; James I Campbell; Nguyen Van Minh Hoang; Maciej F Boni; Phan Vu Tra My; Christopher Parry; Tran Thi Thu Nga; Pham Van Minh; Cao Thu Thuy; To Song Diep; Le Thi Phuong; Mai Thu Chinh; Ha Thi Loan; Nguyen Thi Hong Tham; Mai Ngoc Lanh; Bui Li Mong; Vo Thi Cuc Anh; Phan Van Be Bay; Nguyen Van Vinh Chau; Jeremy Farrar; Stephen Baker
Journal:  BMC Infect Dis       Date:  2009-12-15       Impact factor: 3.090

6.  Establishment of a Shigella sonnei human challenge model in Thailand.

Authors:  Ladaporn Bodhidatta; Punnee Pitisuttithum; Supat Chamnanchanant; Karen T Chang; Dilara Islam; Valai Bussaratid; Malabi M Venkatesan; Thomas L Hale; Carl J Mason
Journal:  Vaccine       Date:  2012-10-12       Impact factor: 3.641

Review 7.  Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984-2005.

Authors:  P K Ram; J A Crump; S K Gupta; M A Miller; E D Mintz
Journal:  Epidemiol Infect       Date:  2007-08-09       Impact factor: 2.451

8.  Epidemiology of highly endemic multiply antibiotic-resistant shigellosis in children in the Peruvian Amazon.

Authors:  Margaret Kosek; Pablo Peñataro Yori; William K Pan; Maribel Paredes Olortegui; Robert H Gilman; Juan Perez; Cesar Banda Chavez; Graciela Meza Sanchez; Rosa Burga; Eric Hall
Journal:  Pediatrics       Date:  2008-08-18       Impact factor: 7.124

9.  Characterization of Shigella sonnei in Malaysia, an increasingly prevalent etiologic agent of local shigellosis cases.

Authors:  Xiu Pei Koh; Chien Shun Chiou; Noni Ajam; Haruo Watanabe; Norazah Ahmad; Kwai Lin Thong
Journal:  BMC Infect Dis       Date:  2012-05-20       Impact factor: 3.090

10.  Changing emergence of Shigella sero-groups in Bangladesh: observation from four different diarrheal disease hospitals.

Authors:  Sumon Kumar Das; Shahnawaz Ahmed; Farzana Ferdous; Fahmida Dil Farzana; Mohammod Jobayer Chisti; Daniel T Leung; Mohammad Abdul Malek; Kaisar Ali Talukder; Pradip Kumar Bardhan; Mohammed Abdus Salam; Abu Syed Golam Faruque; Rubhana Raqib
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.